DERM vs SGEN
Journey Medical Corp (DERM) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
SGEN (SGEN) common stock.
Latest reported DERM revenue for 2026-06-30 was $34.5M. Net income was -$2.5M. DERM currently screens at market cap $163.1M.
SGEN does not have a complete income-statement cache yet.
DERM currently screens at market cap $163.1M.
Not investment advice. Open the DERM and SGEN stock pages for the full models.
Not investment advice.